Skip to content

XONAR

Active
Private limited companyfounded 2022active for 3 yearsVaatjesstraat 5, 2580 Putte, BelgiumKBO/BCE: BE 0793.600.649
Summary

XONAR has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €51,733 and a net result of -€7,077. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 50% of 74 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Financials · financial year 2025, micro format

Equity
€51,733▼ 12.0%
2024 · €58,811
Total assets
€143,913▲ 17.6%
2024 · €122,334
Net result
-€7,077
2024 · €24,028
Working capital
€12,328▼ 38.3%
2024 · €19,969
Trend over the years

2023 to 2025, 3 financial years

The operating result turns negative in 2025: a loss of €3,556 after €33,726 in 2024, the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€3,556 2025 Net result-€7,077 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€46,158-€33,726▼ 26.9%-€3,556
Net result€33,783within the sector's middle half-€24,028within the sector's middle half▼ 28.9%-€7,077within the sector's middle half
Equity€34,783within the sector's middle half-€58,811within the sector's middle half▲ 69.1%€51,733within the sector's middle half▼ 12.0%
Total assets€62,734below the sector's middle half-€122,334within the sector's middle half▲ 95.0%€143,913within the sector's middle half▲ 17.6%
Debt€27,951-€63,523▲ 127%€92,180▲ 45.1%
Working capital€18,952within the sector's middle half-€19,969within the sector's middle half▲ 5.4%€12,328within the sector's middle half▼ 38.3%
Solvency55.4%within the sector's middle half-48.1%within the sector's middle half▼ 7.4pp35.9%within the sector's middle half▼ 12.1pp
Current ratio1.68within the sector's middle half-1.47within the sector's middle half▼ 0.211.24within the sector's middle half▼ 0.23
Return on assets (ROA)53.9%above the sector's middle half-19.6%above the sector's middle half▼ 34.2pp-4.9%within the sector's middle half▼ 24.6pp
above within below the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €143,913
Fixed assets €80,170 ▲ 34.3%
Current assets €63,743 ▲ 1.8%
Equity and liabilities €143,913
Equity €51,733 ▼ 12.0%
Debt €92,180 ▲ 45.1%
Debt's share of the balance-sheet total rises from 51.9% to 64.1%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€12,999▼
2024 · €37,174
Cash flow
€9,477▼
2024 · €27,476
Debt to equity
1.78▲
2024 · 1.08
ROE
-13.7%▼
2024 · 40.9%
Interest coverage
3.75▼
2024 · 13.63
Debt ≤ 1 year
€51,415▲
2024 · €42,669
Debt > 1 year
€40,765▲
2024 · €20,854
Income taxes
€81▼
2024 · €6,985
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,146 companies that looked in July 2024 the way this one looks now, 2.2% went bankrupt within 24 months and 91.6% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a small loss
2.2% went bankrupt
5.9% stopped otherwise
91.6% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,146 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€122,334€143,913▲
Fixed assets21/28€59,696€80,170▲
Intangible fixed assets21€5,883€5,655▼
Tangible fixed assets22/27€53,814€74,515▲
Plant, machinery and equipment23€6,940€22,687▲
Furniture and vehicles24€30,243€34,243▲
Other tangible fixed assets26€16,630€17,585▲
Current assets29/58€62,638€63,743▲
Amounts receivable within one year40/41€20,332€48,596▲
Trade receivables40€17,822€45,637▲
Other amounts receivable41€2,510€2,959▲
Cash at bank and in hand54/58€41,134€12,534▼
Deferred charges and accrued income490/1€1,171€2,613▲
Equity and liabilities
Total equity and liabilities10/49€122,334€143,913▲
Equity10/15€58,811€51,733▼
Contributions10/11€1,000€1,000=
Reserves13€57,811€57,811=
Distributable reserves133€57,811€57,811=
Profit (loss) carried forward14--€7,077
Amounts payable17/49€63,523€92,180▲
Amounts payable after more than one year17€20,854€40,765▲
Financial debts170/4€20,854€40,765▲
Amounts payable within one year42/48€42,669€51,415▲
Current portion of amounts payable after more than one year42€22,035€18,483▼
Financial debts43-€3,079
Credit institutions430/8-€3,079
Trade debts44€2,939€27,734▲
Suppliers440/4€2,939€27,734▲
Taxes, remuneration and social security45€7,579€1,566▼
Taxes450/3€5,349€1,566▼
Remuneration and social security454/9€2,230€0▼
Other amounts payable47/48€10,115€553▼
Income statement Code20242025
Non-recurring operating income76A-€1,689
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,448€16,554▲
Other operating charges640/8€591€1,121▲
Gross operating margin9900€37,765€14,120▼
Operating profit (loss)9901€33,726-€3,556▼
Financial income75/76B€13€30▲
Recurring financial income75€13€30▲
Financial charges65/66B€2,727€3,471▲
Recurring financial charges65€2,727€3,471▲
Profit (loss) for the period before taxes9903€31,013-€6,997▼
Income taxes67/77€6,985€81▼
Profit (loss) for the period9904€24,028-€7,077▼
Profit (loss) for the period to be appropriated9905€24,028-€7,077▼
Appropriation of the result
Profit (loss) to be appropriated9906€24,028-€7,077▼
Transfer to equity691/2€24,028€0▼
To other reserves6921€24,028€0▼

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Non-recurring operating income76A--€1,689-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€867€3,448€16,554▲ 380%
Other operating charges640/8€677€591€1,121▲ 89.6%
Gross operating margin9900€47,702€37,765€14,120▼ 62.6%
Operating profit (loss)9901€46,158€33,726-€3,556-
Financial income75/76B€1€13€30▲ 123%
Recurring financial income75€1€13€30▲ 123%
Financial charges65/66B€3,011€2,727€3,471▲ 27.3%
Recurring financial charges65€3,011€2,727€3,471▲ 27.3%
Profit (loss) for the period before taxes9903€43,148€31,013-€6,997-
Income taxes67/77€9,365€6,985€81▼ 98.8%
Profit (loss) for the period9904€33,783€24,028-€7,077-
Profit (loss) for the period to be appropriated9905€33,783€24,028-€7,077-
Line202320242025Change
Assets
Total assets20/58€62,734€122,334€143,913▲ 17.6%
Fixed assets21/28€15,831€59,696€80,170▲ 34.3%
Intangible fixed assets21-€5,883€5,655▼ 3.9%
Tangible fixed assets22/27€15,831€53,814€74,515▲ 38.5%
Plant, machinery and equipment23€1,058€6,940€22,687▲ 227%
Furniture and vehicles24-€30,243€34,243▲ 13.2%
Other tangible fixed assets26€14,772€16,630€17,585▲ 5.7%
Current assets29/58€46,904€62,638€63,743▲ 1.8%
Amounts receivable within one year40/41€14,469€20,332€48,596▲ 139%
Trade receivables40€14,469€17,822€45,637▲ 156%
Other amounts receivable41-€2,510€2,959▲ 17.9%
Cash at bank and in hand54/58€30,860€41,134€12,534▼ 69.5%
Deferred charges and accrued income490/1€1,575€1,171€2,613▲ 123%
Equity and liabilities
Total equity and liabilities10/49€62,734€122,334€143,913▲ 17.6%
Equity10/15€34,783€58,811€51,733▼ 12.0%
Contributions10/11€1,000€1,000€1,000=
Reserves13€33,783€57,811€57,811=
Distributable reserves133€33,783€57,811€57,811=
Profit (loss) carried forward14---€7,077-
Amounts payable17/49€27,951€63,523€92,180▲ 45.1%
Amounts payable after more than one year17-€20,854€40,765▲ 95.5%
Financial debts170/4-€20,854€40,765▲ 95.5%
Amounts payable within one year42/48€27,951€42,669€51,415▲ 20.5%
Current portion of amounts payable after more than one year42-€22,035€18,483▼ 16.1%
Financial debts43--€3,079-
Credit institutions430/8--€3,079-
Trade debts44€1,798€2,939€27,734▲ 844%
Suppliers440/4€1,798€2,939€27,734▲ 844%
Taxes, remuneration and social security45€12,400€7,579€1,566▼ 79.3%
Taxes450/3€10,204€5,349€1,566▼ 70.7%
Remuneration and social security454/9€2,196€2,230€0▼ 100%
Other amounts payable47/48€13,754€10,115€553▼ 94.5%
Line202320242025Change
Profit (loss) for the period9904€33,783€24,028-€7,077-
+ Depreciation and write-downs630€867€3,448€16,554▲ 380%
Operating cash flow (approximation)€34,650€27,476€9,477▼ 65.5%
Investment in fixed assets (approximation)--€47,313-€37,028▲ 21.7%
Change in cash-€10,274-€28,601-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 13-07-2026 2026-00284146
31-12-2024 micro format 15-07-2025 2025-00268785
31-12-2023 micro format 04-07-2024 2024-00212939

Similar companies · same sector, comparable size

Of the 148 active companies whose main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100), figures are known for 109. 55 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2024 · 1 entry · €393 awarded · €243 paid
Schemes
1 entry · €393 · €243 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.